Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells (iPSCs). This report contains market size and forecasts of Induced Pluripotent Stem Cells (iPSCs) in global, including the following market information:
Global Induced Pluripotent Stem Cells (iPSCs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 104.4 million in 2022 and is projected to reach US$ 227.6 million by 2029, at a CAGR of 11.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
We surveyed the Induced Pluripotent Stem Cells (iPSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Induced Pluripotent Stem Cells (iPSCs) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, by Type, 2022 (%)
Human iPSCs
Mouse iPSCs
Global Induced Pluripotent Stem Cells (iPSCs) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, by Application, 2022 (%)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Global Induced Pluripotent Stem Cells (iPSCs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Induced Pluripotent Stem Cells (iPSCs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Induced Pluripotent Stem Cells (iPSCs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Induced Pluripotent Stem Cells (iPSCs), market overview.
Chapter 2: Global Induced Pluripotent Stem Cells (iPSCs) market size in revenue.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Induced Pluripotent Stem Cells (iPSCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Induced Pluripotent Stem Cells (iPSCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Induced Pluripotent Stem Cells (iPSCs) Overall Market Size
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size: 2022 VS 2029
2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Induced Pluripotent Stem Cells (iPSCs) Players in Global Market
3.2 Top Global Induced Pluripotent Stem Cells (iPSCs) Companies Ranked by Revenue
3.3 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Companies
3.4 Top 3 and Top 5 Induced Pluripotent Stem Cells (iPSCs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Induced Pluripotent Stem Cells (iPSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Players in Global Market
3.6.1 List of Global Tier 1 Induced Pluripotent Stem Cells (iPSCs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Market Size Markets, 2022 & 2029
4.1.2 Human iPSCs
4.1.3 Mouse iPSCs
4.2 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
4.2.1 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
4.2.2 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
4.2.3 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Market Size, 2022 & 2029
5.1.2 Academic Research
5.1.3 Drug Development and Discovery
5.1.4 Toxicity Screening
5.1.5 Regenerative Medicine
5.1.6 Others
5.2 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
5.2.1 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
5.2.2 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
5.2.3 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Market Size, 2022 & 2029
6.2 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
6.2.1 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
6.2.2 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
6.2.3 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.3.2 US Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.3.3 Canada Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.3.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.4.2 Germany Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.3 France Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.4 U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.5 Italy Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.6 Russia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.7 Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.8 Benelux Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.5.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.4 South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.5 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.6 India Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.6.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.6.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.7.2 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.4 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.5 UAE Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
7 Induced Pluripotent Stem Cells (iPSCs) Companies Profiles
7.1 Fujifilm Holding Corporation (CDI)
7.1.1 Fujifilm Holding Corporation (CDI) Company Summary
7.1.2 Fujifilm Holding Corporation (CDI) Business Overview
7.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.1.5 Fujifilm Holding Corporation (CDI) Key News & Latest Developments
7.2 Ncardia
7.2.1 Ncardia Company Summary
7.2.2 Ncardia Business Overview
7.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.2.5 Ncardia Key News & Latest Developments
7.3 Sumitomo Dainippon Pharma
7.3.1 Sumitomo Dainippon Pharma Company Summary
7.3.2 Sumitomo Dainippon Pharma Business Overview
7.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.3.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.4 Astellas Pharma Inc
7.4.1 Astellas Pharma Inc Company Summary
7.4.2 Astellas Pharma Inc Business Overview
7.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma Inc Key News & Latest Developments
7.5 Fate Therapeutics, Inc
7.5.1 Fate Therapeutics, Inc Company Summary
7.5.2 Fate Therapeutics, Inc Business Overview
7.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.5.5 Fate Therapeutics, Inc Key News & Latest Developments
7.6 Pluricell Biotech
7.6.1 Pluricell Biotech Company Summary
7.6.2 Pluricell Biotech Business Overview
7.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.6.5 Pluricell Biotech Key News & Latest Developments
7.7 Cell Inspire Biotechnology
7.7.1 Cell Inspire Biotechnology Company Summary
7.7.2 Cell Inspire Biotechnology Business Overview
7.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.7.5 Cell Inspire Biotechnology Key News & Latest Developments
7.8 ReproCELL
7.8.1 ReproCELL Company Summary
7.8.2 ReproCELL Business Overview
7.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.8.5 ReproCELL Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Opportunities & Trends in Global Market
Table 2. Induced Pluripotent Stem Cells (iPSCs) Market Drivers in Global Market
Table 3. Induced Pluripotent Stem Cells (iPSCs) Market Restraints in Global Market
Table 4. Key Players of Induced Pluripotent Stem Cells (iPSCs) in Global Market
Table 5. Top Induced Pluripotent Stem Cells (iPSCs) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Induced Pluripotent Stem Cells (iPSCs) Product Type
Table 9. List of Global Tier 1 Induced Pluripotent Stem Cells (iPSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Induced Pluripotent Stem Cells (iPSCs) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Induced Pluripotent Stem Cells (iPSCs) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Induced Pluripotent Stem Cells (iPSCs) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Induced Pluripotent Stem Cells (iPSCs) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2024-2029
Table 30. Fujifilm Holding Corporation (CDI) Company Summary
Table 31. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 32. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 33. Fujifilm Holding Corporation (CDI) Key News & Latest Developments
Table 34. Ncardia Company Summary
Table 35. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 36. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 37. Ncardia Key News & Latest Developments
Table 38. Sumitomo Dainippon Pharma Company Summary
Table 39. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 40. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 41. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 42. Astellas Pharma Inc Company Summary
Table 43. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 44. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 45. Astellas Pharma Inc Key News & Latest Developments
Table 46. Fate Therapeutics, Inc Company Summary
Table 47. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 48. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 49. Fate Therapeutics, Inc Key News & Latest Developments
Table 50. Pluricell Biotech Company Summary
Table 51. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 52. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 53. Pluricell Biotech Key News & Latest Developments
Table 54. Cell Inspire Biotechnology Company Summary
Table 55. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 56. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 57. Cell Inspire Biotechnology Key News & Latest Developments
Table 58. ReproCELL Company Summary
Table 59. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offerings
Table 60. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (US$, Mn) & (2018-2023)
Table 61. ReproCELL Key News & Latest Developments
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Segment by Type in 2022
Figure 2. Induced Pluripotent Stem Cells (iPSCs) Segment by Application in 2022
Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2022
Figure 8. By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 16. US Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 20. Germany Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 21. France Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 28. China Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 32. India Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 34. Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
Figure 37. Turkey Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$, Mn), 2018-2029
Figure 41. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
